Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

PURPOSE: To examine the association between beta-blocker (BB) intake, pathologic complete response (pCR) rates, and survival outcomes in patients with breast cancer treated with neoadjuvant chemotherapy. PATIENTS AND METHODS: We retrospectively reviewed 1,413 patients with breast cancer who received...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Melhem-Bertrandt, Amal, Chavez-MacGregor, Mariana, Lei, Xiudong, Brown, Erika N., Lee, Richard T., Meric-Bernstam, Funda, Sood, Anil K., Conzen, Suzanne D., Hortobagyi, Gabriel N., Gonzalez-Angulo, Ana-Maria
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3139371/
https://ncbi.nlm.nih.gov/pubmed/21632501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.33.4441
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados